Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies

TOP News

stop-coronavirus

Five Companies Must Withdraw Metformin Drugs from the Market

FDA is announcing that agency laboratory testing has revealed levels of the nitrosamine impurity N-Nitrosodimethylamine (NDMA) above the agency’s acceptable intake limit in several lots of the extende...

EMA Reminded of the Risks of Chloroquine and Hydroxychloroquine

EMA is reminding healthcare professionals to closely monitor patients with COVID-19 who are receiving chloroquine or hydroxychloroquine, given the serious side effects that can result from treatment w...

Advent Manufactured the First 4000 Doses of the AZD1222 Vaccine for Clinical Trial

Advent Srl announces it has manufactured 13,000 doses of the novel Covid-19 vaccine candidate, ChAdOx1 nCoV-19 (now known as AZD1222). The first 4,000 doses have been delivered for use in the Phase 2/...

Sun Pharma Receives Approval to Initiate Clinical Trial with Nafamostat for Covid-19

Sun Pharmaceutical Industries Ltd. has announced that it has received approval from the Drugs Controller General of India (DCGI) to initiate a clinical trial with Nafamostat Mesilate in Covid-19 patie...

CHMP Recommended Eight New Drugs for Approval

EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its May 2020 meeting. The Committee recommended granting a marketing authorisation for a new vaccine that provides...

Gilead and Arcus Establish 10-year Partnership to Develop Cancer Immunotherapies

Gilead Sciences, Inc. and Arcus Biosciences, Inc. announced that the companies have entered into a 10-year partnership to co-develop and co-commercialize current and future therapeutic product candida...

GSK Intends to Produce 1 Billion Doses of Pandemic Vaccine Adjuvant in 2021

GSK confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant system, in 2021, to support the development of multiple adjuvanted COVID-19 vaccine candidates. GSK belie...

Subscribe to GMP news Newsletter!

Oops...
Slider with alias new year v02 not found.

Interview

COVID-19: Triazavirin Production Goes Up to 7 Thousand Packs per Day

Because of Covid-19, the pharmaceutical company Medsintez increased the production of Triazavirin from 3 to 7 thousand packages per day. The data was announced by the head of the Department of Organic...

Developing a Vaccine will be Crucial in the Global Fight Against Covid-19

Interview with Heinz Schmidt, Director of Merck Life Science, Russia & CIS, on the situation in the pharmaceutical industry associated with COVID-19. Is it possible to consider the coronavirus ...

Even if the Vaccine Appears Tomorrow, it Will not Help Cure the Existing Patients

Andrey Kiyasov, Vice-Rector for Biomedicine, Director of the Institute of Fundamental Medicine and Biology, gave comments to a local online news portal. On KFU’s research in COVID vaccine At KFU...

Is there a Connection Between Antimicrobial Resistance and COVID-19?

As America’s biopharmaceutical companies work around the clock to combat COVID-19, a disease caused by a novel strain of coronavirus, now is an important time to consider how we can prepare for the ne...

Subscribe to GMP news Newsletter!

Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies